Applications due Dec. 8
These instructions are for VU investigators. VUMC investigators should visit the OOR funding opportunity site.
Vanderbilt University may nominate one candidate for the Mary Kay Ash Foundation Translational Cancer Research Grant program for 2022. These awards provide $100,000 over two years to support translational research in ovarian, uterine, breast or cervical cancer.
The foundation seeks to fund innovative research that will provide a scientific link between laboratory research and the clinic. Ultimately, such research would lead to improvement in the diagnosis, prognosis, prevention or treatment of cancer.
- Principal investigator must be full-time assistant professor or higher (assistant, associate or full professor) and commit a minimum 5 percent effort.
- Staff scientists, postdoctoral trainees and instructors are NOT eligible.
- Up to one co-PI is permitted. Co-PI must meet the same eligibility requirements as PI (assistant professor or higher).
- Postdoc contributors may be listed as co-investigator but not co-PI.
- The maximum total budget is $100,000. Indirect costs may not exceed 15 percent of direct costs (e.g., direct costs ≤ $86,956; indirect costs ≤ $13,044).
- U.S. citizenship is not required.
Timeline: The chosen nominee will submit a full proposal to the foundation by the deadline of Feb. 4, 2022.
Internal submission instructions
Interested faculty should visit https://vanderbilt.infoready4.com/#competitionDetail/1855732 to submit an application for the internal LSO competition and to find additional information about the opportunity. The deadline for the internal competition is Dec. 8, 2021.
Any questions about this opportunity or the LSO process may be directed to VU-LSO@vanderbilt.edu.